Table 3.
AASa user group |
Control group |
p value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Beck Anxiety Inventory scores | |||||
Normal (<8) | 18 | 72 | 25 | 100 | 0.010* |
Mild anxiety symptoms (8–15) | 7 | 28 | 0 | 0 | |
Moderate anxiety symptoms (16–25) | 0 | 0 | 0 | 0 | |
Severe anxiety symptoms (26–63) | 0 | 0 | 0 | 0 | |
Beck Depression Inventory scores | |||||
Normal (<10) | 18 | 72 | 25 | 100 | 0.012* |
Mild depressive symptoms (10–16) | 4 | 16 | 0 | 0 | |
Moderate depressive symptoms (17–29) | 3 | 12 | 0 | 0 | |
Severe depressive symptoms (30–63) | 0 | 0 | 0 | 0 |
aAAS, anabolic-androgenic steroids.
* Fisher Exact Testing.